VSIG2 and neoplasm: V-set and immunoglobulin domain-containing 2 (VSIG2) is an emerging B7-like immune checkpoint whose expression topography has quietly shifted from a “thymocyte relic” to a decisive regulator of tumor–immune crosstalk[5].